Literature DB >> 10336838

ATP-sensitive K+ channels mediate the delayed cardioprotective effect of adenosine A1 receptor activation.

G F Baxter1, D M Yellon.   

Abstract

Adenosine A1 receptor stimulation increases myocardial resilience to ischaemia many hours later but the mechanism of protection is unclear. We hypothesized that A1 receptor-induced delayed cardioprotection is mediated by KATP channel opening. Rabbits were pretreated with saline or the selective A1 receptor agonist 2-chloro-N6-cyclopentyladenosine (CCPA), 0.1 mg/kg i.v. After 24 h, they were anaesthetized and subjected to 30 min left coronary artery occlusion (CAO) and 120 min reperfusion. Twenty minutes before CAO, either glibenclamide 0.3 mg/kg, sodium 5-hydroxydecanoate (5-HD) 5 mg/kg, or a corresponding volume of vehicle solution were given i.v. Infarct size as a percentage of ischaemic risk volume (I/R%) was assessed by triphenyltetrazolium. In the absence of either glibenclamide or 5-HD, CCPA pretreatment resulted in significant limitation of infarction (I/R 23.4+/-3.3%vs 39.6+/-2.6% in saline pretreated animals, P<0.01). Administration of glibenclamide before CAO abolished this delayed protective effect of CCPA (I/R 37.4+/-4. 7%), as did 5-HD (I/R 48.8+/-3.7%). Neither glibenclamide nor 5-HD significantly modified I/R in saline pretreated animals. Risk volume was similar in all groups (0.8-1.1 cm3). Systemic haemodynamic variables were not markedly different between any of the groups immediately before or during the ischaemia-reperfusion protocol. Thus, delayed protection following transient A1 receptor activation was abolished by pre-ischaemic treatment with either glibenclamide or 5-HD, providing pharmacological evidence that KATP channel opening mediates A1 agonist-induced delayed myocardial protection. The inhibitory effect of 5-HD suggests specific involvement of mitochondrial KATP but the mechanisms of sub-acute regulation of KATP function following A1 receptor stimulation remain to be determined. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10336838     DOI: 10.1006/jmcc.1999.0927

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  7 in total

1.  Conditioned medium from hypoxic cells protects cardiomyocytes against ischemia.

Authors:  B Chanyshev; A Shainberg; A Isak; Y Chepurko; E Porat; E Hochhauser
Journal:  Mol Cell Biochem       Date:  2011-12-08       Impact factor: 3.396

Review 2.  Nitrite as a mediator of ischemic preconditioning and cytoprotection.

Authors:  Daniel Murillo; Christelle Kamga; Li Mo; Sruti Shiva
Journal:  Nitric Oxide       Date:  2011-01-26       Impact factor: 4.427

3.  ATP-sensitive K(+) channels regulate the concentrative adenosine transporter CNT2 following activation by A(1) adenosine receptors.

Authors:  Sylvie Duflot; Bárbara Riera; Sonia Fernández-Veledo; Vicent Casadó; Robert I Norman; F Javier Casado; Carme Lluís; Rafael Franco; Marçal Pastor-Anglada
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

4.  Pharmacological inhibition of GSK-3β produces late phase of cardioprotection in hyperlipidemic rat: possible involvement of HSP 72.

Authors:  Harlokesh Narayan Yadav; Manjeet Singh; Pyare Lal Sharma
Journal:  Mol Cell Biochem       Date:  2012-07-19       Impact factor: 3.396

5.  Mechanisms whereby glucose deprivation triggers metabolic preconditioning in the isolated rat heart.

Authors:  M M Awan; S Makaula; S Forresti; M N Sack; L H Opie
Journal:  Mol Cell Biochem       Date:  2000-08       Impact factor: 3.396

6.  Cardioprotection afforded by chronic exercise is mediated by the sarcolemmal, and not the mitochondrial, isoform of the KATP channel in the rat.

Authors:  David A Brown; Adam J Chicco; Korinne N Jew; Micah S Johnson; Joshua M Lynch; Peter A Watson; Russell L Moore
Journal:  J Physiol       Date:  2005-10-13       Impact factor: 5.182

Review 7.  Mechanisms involved in adenosine pharmacological preconditioning-induced cardioprotection.

Authors:  Lovedeep Singh; Ritu Kulshrestha; Nirmal Singh; Amteshwar Singh Jaggi
Journal:  Korean J Physiol Pharmacol       Date:  2018-04-25       Impact factor: 2.016

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.